poor-risk mutations
Showing 1 - 25 of >10,000
Liver Cirrhosis Trial (Human albumin, Enoxaparin, Standard medical treatment)
Not yet recruiting
- Liver Cirrhosis
- Human albumin
- +2 more
- (no location specified)
Jun 6, 2023
Lung Cancer Trial in Boston, Nashville
Active, not recruiting
- Lung Cancer
-
Boston, Massachusetts
- +1 more
Dec 28, 2022
Parkinson Disease Trial in Pozzilli (targeted resequencing)
Recruiting
- Parkinson Disease
- targeted resequencing
-
Pozzilli, ItalyIRCCS Neuromed
Sep 27, 2022
Non-Seminomatous Germ Cell Tumor Trial in Villejuif (BEP Protocol, Dose-dense regimen, Early tumor resection or HD-CT)
Not yet recruiting
- Non-Seminomatous Germ Cell Tumor
- BEP Protocol
- +2 more
-
Villejuif, FranceGustave Roussy
Jan 27, 2023
Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning)
Active, not recruiting
- Hodgkin Lymphoma
- Brentuximab Vedotin
- +2 more
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
New Genetic Mutations in Thromboembolic Venous Disease
Completed
- Thromboembolic Venous Disease
- Genetic sample
-
Brest, FranceCHRU de Brest
Mar 3, 2022
Poor Vascular Health in Youth
Completed
- Prehypertension
- +6 more
- Cardiovascular Assessments
- +3 more
-
Baltimore, MarylandJohns Hopkins School of Medicine Division of Pediatric Nephrolog
Jun 21, 2022
Chronic Kidney Disease-related Sarcopenia With Poor Prognosis
Recruiting
- Chronic Kidney Diseases
- Sarcopenia
- No intervention
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
May 9, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- Sargramostim
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022
Esophageal Cancer, Esophageal Tumors Trial in Boston (Prehabilitation Program)
Not yet recruiting
- Esophageal Cancer
- Esophageal Neoplasms
- Prehabilitation Program
-
Boston, MassachusettsMassachusetts General Hospital
Sep 6, 2023
Auto/Allo Tandem Transplant for Relapsed B-NHL
Completed
- Non Hodgkin Lymphoma
- auto transplant followed by allo transplant
- (no location specified)
Oct 24, 2022
SCREEN to Persons Living With Dementia or in Retirement Homes
Enrolling by invitation
- Malnutrition
- +2 more
-
Guelph, Ontario, CanadaHeather Keller
Oct 19, 2022
MDS Trial in Miami, New York (50 gm CIVI/24 hours x 5 days every 4 week)
Recruiting
- Myelodysplastic Syndromes
- 50 gm CIVI/24 hours x 5 days every 4 week
-
Miami, Florida
- +1 more
Jul 6, 2022
Prostate Cancer Metastatic, Metastasis Trial in Netherlands (Cabazitaxel, Abiraterone, Enzalutamide)
Completed
- Prostate Cancer Metastatic
- Metastasis
- Cabazitaxel
- +2 more
-
Alkmaar, Netherlands
- +18 more
Apr 14, 2022
Cancer Trial in Los Angeles (KRAS-variant and microRNA binding site mutation testing)
Recruiting
- Cancer
- KRAS-variant and microRNA binding site mutation testing
-
Los Angeles, CaliforniaMiraKind
Aug 24, 2021
Osteo Arthritis Knee Trial in Tampere (Smart ring assisted physiotherapeutic intervention)
Recruiting
- Osteo Arthritis Knee
- Smart ring assisted physiotherapeutic intervention
-
Tampere, Pirkanmaa, FinlandCoxa Hospital for Joint Replacement
Nov 9, 2022
Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)
Completed
- Leukemia
- +2 more
- Selinexor
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022
Associated With Colorectal Cancer
Not yet recruiting
- Colorectal Neoplasms
- Assessment of smoking ,heavy metal, organophosphorus exposure and d) Mutational analysis of the KRAS and BRAF genes:
- (no location specified)
Dec 18, 2021
Diabetes, Non Insulin Dependent Diabetes Trial in New York (Telehealth Bridge Visits, Standard of Care)
Not yet recruiting
- Diabetes Mellitus
- Non Insulin Dependent Diabetes Mellitus
- Telehealth Bridge Visits
- Standard of Care
-
New York, New YorkNYU Langone Health
Jun 2, 2023
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Mar 28, 2023
Early HER2-negative High-risk Breast Cancer and BRCA1/2
Not yet recruiting
- Breast Cancer
-
Arkhangelsk, Russian Federation
- +19 more
Jul 3, 2023
Pancreas Cancer, Pancreatitis, Chronic Pancreatitis Trial in New York
Recruiting
- Pancreas Cancer
- +5 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 18, 2022
Bayesian Networks in Pediatric Cardiac Surgery
Recruiting
- Cardiac Surgical Procedures
- +2 more
- Pediatric cardiac surgery under cardiopulmonary bypass
-
Brussels, BelgiumHôpital Universitaire des Enfants Reine Fabiola
Sep 16, 2022
Modifier Testing Among Women With BRCA1/2 Mutations
Enrolling by invitation
- Mastectomy; Lymphedema
- Genetic Risk Modifier testing
-
Philadelphia, PennsylvaniaAbramson Cancer Center University of Pennsylvania
Jun 23, 2021
Stem Cell Transplant Complications Trial in Beijing (N-acetyl-L-cysteine)
Active, not recruiting
- Stem Cell Transplant Complications
-
Beijing, ChinaPeking University People's Hospital
Sep 13, 2021